Unveiling mortality risk factors in paediatric sickle cell disease patients during acute crises in the Democratic Republic of the Congo

被引:3
|
作者
Boma, Paul Muteb [1 ]
Ngimbi, Stephanie Luntadila [2 ]
Kindundu, Junior Makiese [1 ]
Wela, Jean Israel [3 ]
Ngoie, Nathalie Lukanke [2 ]
Ngwamah, Valentin Mukeba [1 ]
Tshiswaka, Sandra Mbuyi [2 ]
Monga, Josephine Kalenga [2 ,4 ]
Panda, Jules Mulefu [1 ,5 ]
Bonnechere, Bruno [6 ,7 ,8 ]
机构
[1] Res Inst Hlth Sci, Reference Ctr Sickle Cell Dis Lubumbashi, Lubumbashi, DEM REP CONGO
[2] Prov Gen Reference Hosp Jason Sendwe, Lubumbashi, DEM REP CONGO
[3] Natl Inst Stat, Kinshasa, DEM REP CONGO
[4] Univ Lubumbashi, Fac Med, Dept Pediat, Lubumbashi, DEM REP CONGO
[5] Univ Lubumbashi, Fac Med, Dept Surg, Lubumbashi, DEM REP CONGO
[6] Univ Hasselt, Fac Rehabil Sci, REVAL Rehabil Res Ctr, Diepenbeek, Belgium
[7] Hasselt Univ, Data Sci Inst, Diepenbeek, Belgium
[8] Agoralaan Bldg A, B-3590 Diepenbeek, Belgium
关键词
Sickle cell disease; Mortality; Assessment; DR Congo; CHILDREN;
D O I
10.1016/j.bcmd.2024.102828
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sickle cell disease (SCD) is a significant health burden in the Democratic Republic of the Congo (DRC). This study aims to identify predictive factors of mortality in SCD children admitted to emergency care in Lubumbashi, DRC. We performed a non -interventional cohort follow-up on SCD patients aged 0 to 16 admitted for a "true emergency". Demographic, clinical, and biological data were collected. Univariate and multivariate logistic regression analyses were performed to identify significant risk factors associated with mortality. Among the 121 patients included, 24 died during the follow-up period. Univariate regression revealed age, Mikobi score, referral origin, stroke, and severe infection as significant risk factors. Multivariate analyses identified Hb, WBC, SR, and LDH as predictive factors of mortality. Notably, patients aged 12 to 16 years faced a higher risk, shifting the age of mortality from early to late childhood and adolescence. This study provides valuable insights into mortality risk factors for paediatric SCD patients during acute crises. Early diagnosis, regular follow-up, and therapeutic education are essential to improve patient outcomes and survival rates. These findings contribute to better disease management and targeted interventions, aiming to reduce mortality associated with SCD.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Classical Risk Factors for Ischemic Stroke are not Associated with Inpatient Post-Stroke Mortality in Sickle Cell Disease
    Miller, Raphael
    Klyde, Daniel M.
    Unda, Santiago R.
    Fluss, Rose
    Altschul, David J.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (12):
  • [42] Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease
    Masera, Nicoletta
    Tavecchia, Luisa
    Pozzi, Lorena
    Riva, Francesca
    Vimercati, Chiara
    Calabria, Manuela
    Ronzoni, Simona
    Masera, Giuseppe
    Perseghin, Paolo
    TRANSFUSION AND APHERESIS SCIENCE, 2007, 37 (03) : 241 - 247
  • [43] Genetic Modulators of Diversity in the Biological Expression of Sickle Cell Anemia in Patients from Democratic Republic of Congo: Role of βs-globin Haplotypes
    Ngole, Mamy
    Mbayabo, Gloire
    Lumbala, Paul
    Race, Valerie
    Mvuama, Nono
    Deman, Stephanie
    Souche, Erika
    Lukusa, Prosper Tshilobo
    Van Geet, Chris
    Devriendt, Koenraad
    Matthijs, Gert
    Lumaka, Aime
    Cleynen, Isabelle
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2025, 17 (01)
  • [44] Outcomes of Acute Chest Syndrome in Adult Patients with Sickle Cell Disease: Predictors of Mortality
    Allareddy, Veerajalandhar
    Roy, Aparna
    Lee, Min Kyeong
    Nalliah, Romesh P.
    Rampa, Sankeerth
    Allareddy, Veerasathpurush
    Rotta, Alexandre T.
    PLOS ONE, 2014, 9 (04):
  • [45] Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe
    Maitra, Poulami
    Caughey, Melissa
    Robinson, Laura
    Desai, Payal C.
    Jones, Susan
    Nouraie, Mehdi
    Gladwin, Mark T.
    Hinderliter, Alan
    Cai, Jianwen
    Ataga, Kenneth I.
    HAEMATOLOGICA, 2017, 102 (04) : 626 - 636
  • [46] An Appraisal of Kidney Dysfunction and Its Risk Factors in Patients with Sickle Cell Disease
    Arogundade, F. A.
    Sanusi, A. A.
    Hassan, M. O.
    Salawu, L.
    Durosinmi, M. A.
    Akinsola, A.
    NEPHRON CLINICAL PRACTICE, 2011, 118 (03): : C225 - C231
  • [47] Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization
    Makani, Julie
    Komba, Albert N.
    Cox, Sharon E.
    Oruo, Julie
    Mwamtemi, Khadija
    Kitundu, Jesse
    Magesa, Pius
    Rwezaula, Stella
    Meda, Elineema
    Mgaya, Josephine
    Pallangyo, Kisali
    Okiro, Emelda
    Muturi, David
    Newton, Charles R.
    Fegan, Gregory
    Marsh, Kevin
    Williams, Thomas N.
    BLOOD, 2010, 115 (02) : 215 - 220
  • [48] A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria
    George O Adjei
    Bamenla Q Goka
    Christabel C Enweronu-Laryea
    Onike P Rodrigues
    Lorna Renner
    Abdul M Sulley
    Michael Alifrangis
    Insaf Khalil
    Jorgen A Kurtzhals
    Malaria Journal, 13
  • [49] Arginine supplementation improves lactate dehydrogenase levels in steady-state sickle cell patients: preliminary findings from Kinshasa, the Democratic Republic of Congo
    Ngonde, Ange C. M.
    Lukanu, Philippe N.
    Mubiala, Ange
    Aloni, Michel N.
    FRONTIERS IN PAIN RESEARCH, 2024, 5
  • [50] Co-occurrence of oculocutaneous albinism type 2 and mild sickle cell disease explained by HbS/βthal genotype in an individual from the Democratic Republic of Congo
    Aquaron, Robert
    Lasseaux, Eulalie
    Kelekele, Joseph
    Bonello-Palot, Nathalie
    Badens, Catherine
    Arveiler, Benoit
    Tshilolo, Leon
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2022, 65 (10)